'Acting' At CDRH: Two Top Offices Are Now Run By Interim Directors
This article was originally published in The Gray Sheet
An update on CDRH's management structure.
You may also be interested in...
John Sheets is leaving US FDA after less than a year serving as director of the Office of Device Evaluation. As a result, Device-center Chief Scientist William Maisel has resumed his role as acting ODE director, a post he filled from 2014 to 2016 before Sheets was hired by the agency.
Device industry veteran John Sheets has been appointed as the new director of FDA's premarket review office for devices. It’s the second time this year that CDRH has tapped an industry executive to lead one of its offices.
The most popular "Gray Sheet" stories in 2015 dug deep into regulatory developments and concepts, and provided guidance on how to respond. Quality control topics and analysis of FDA's premarket review processes dominates the list.